Biognosys dispatches cutting edge answer for finding blood biomarkers
The better than ever administration gives remarkable profundity, accuracy and throughput, measuring up to 3,000 proteins in plasma or serum
Biognosys, an innovator in proteomics answers for drug disclosure and improvement, today reports the dispatch of its cutting edge blood biomarker revelation arrangement, which will be presented as an agreement research administration. The assistance is intended to assist specialists with interpreting the intricacies of the blood proteome and open impartial disclosures for drug improvement and diagnostics and accuracy medication.
“Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era.”
Tweet this
The dispatch will include a progression of occasions and assets itemizing the science and innovation behind the new arrangement, just as its applications:
Dispatch online class on November 9 named: “Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era.”
Show and display at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 12-14 in Washington, D.C.
This declaration is authoritatively substantial in the first source language. Interpretations are just expected as an understanding guide and ought to be contrasted and the text in the source language, which is the main lawfully legitimate one.
